Silverberg K M
Division of Reproductive Endocrinology and Infertility, University of Texas Health Sciences Center, San Antonio, USA.
Semin Reprod Endocrinol. 1996 Nov;14(4):339-44. doi: 10.1055/s-2008-1067978.
Controlled ovarian hyperstimulation is frequently employed as empiric therapy for the treatment of unexplained infertility, mild male factor, cervical factor, and treated endometriosis. Prescribed in the form of either clomiphene citrate or gonadotropins, it is often combined with intrauterine insemination and offered to patients as a less expensive and less invasive alternative to the assisted reproductive technologies. Efficacy studies for these regimens are very important, as patients who would appear to be ideal candidates for this empiric therapy frequently do not suffer from absolute infertility; rather they are often subfertile, and may conceive spontaneously given enough time. Although there are few well-designed, controlled trials that assess the effectiveness of this form of therapy, the majority of the published data do suggest an improvement in pregnancy rates when compared to expectant management.
控制性卵巢刺激常用于不明原因不孕、轻度男性因素不孕、宫颈因素不孕及经治疗的子宫内膜异位症的经验性治疗。以枸橼酸氯米芬或促性腺激素的形式给药,常与宫腔内人工授精联合使用,作为辅助生殖技术之外费用较低且侵入性较小的替代方案提供给患者。这些治疗方案的疗效研究非常重要,因为看似适合这种经验性治疗的理想候选患者往往并非绝对不孕;相反,他们通常是生育力低下,且给予足够时间可能会自然受孕。尽管评估这种治疗方式有效性的精心设计的对照试验很少,但大多数已发表的数据确实表明,与期待治疗相比,妊娠率有所提高。